Clinical Trial Update: PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. [Phase 1]

View source ↗

Summary

Evaluates the PRORAD-5 five-fraction radiotherapy regimen for advanced prostate cancer in early-phase trials. The study is currently recruiting at MD Anderson C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Prostate Cancer | Phase 1 | Status: RECRUITING